Biosynex Logo

Biosynex

ALBIO | PA

Overview

Corporate Details

ISIN(s):
FR0011005933
LEI:
969500H4BGE1HBLGP566
Country:
France
Address:
22 BOULEVARD SEBASTIEN BRANT, 67400 ILLKIRCH-GRAFFENSTADEN
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Founded in 2005, Biosynex is a key European manufacturer specializing in the in-vitro diagnostics market. The company designs, manufactures, and distributes Rapid Diagnostic Tests (RDTs) for both professional and public use. Its product portfolio includes Point-of-Care (POC) solutions, molecular biology assays, and self-tests available in pharmacies, which are utilized for screening, diagnosis, and prevention. Biosynex's tests are engineered for speed and simplicity, aiming to facilitate better medical management and patient care. The company distributes its products internationally to over 90 countries, serving healthcare professionals such as biologists and doctors, as well as the general consumer market.

Social Media

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for Biosynex. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-07-29 18:45
Regulatory News Service
BIOSYNEX SA: LA FOOD AND DRUG ADMINSITRATION ATTRIBUE LE STATUT BREAKTHROUGH DE…
French 28.7 KB
2025-07-17 18:00
Earnings Release
BIOSYNEX SA: CHIFFRE DAFFAIRES DU PREMIER SEMESTRE 2025 : 50,8 M (-6%)
French 50.6 KB
2025-06-17 18:00
Regulatory News Service
BIOSYNEX SA: LA FOOD AND DRUG ADMINSITRATION ATTRIBUE LE STATUT “BREAKTHROUGH D…
French 329.2 KB
2025-06-17 18:00
Regulatory News Service
BIOSYNEX SA: LA FOOD AND DRUG ADMINSITRATION ATTRIBUE LE STATUT BREAKTHROUGH DE…
French 29.2 KB
2025-04-23 18:00
Earnings Release
BIOSYNEX SA: RESULTATS ANNUELS 2024 - ACCELERATION DE LA REORGANISATION DU GROU…
French 389.4 KB
2025-04-23 18:00
Earnings Release
BIOSYNEX SA: RESULTATS ANNUELS 2024 - ACCELERATION DE LA REORGANISATION DU GROU…
French 108.9 KB
2025-03-06 18:03
Major Shareholding Notification
Franchissement de seuil
French 221.4 KB
2025-03-05 18:00
Declaration of Voting Results & Voting Rights Announcements
BIOSYNEX SA: DECLARATION DU NOMBRE DACTIONS ET DES DROITS DE VOTE AU 28 FEVRIER…
French 23.2 KB
2025-03-04 18:00
Declaration of Voting Results & Voting Rights Announcements
BIOSYNEX SA: DECLARATION DU NOMBRE D’ACTIONS ET DES DROITS DE VOTE AU 28 FEVRIE…
French 127.2 KB
2025-03-04 18:00
Declaration of Voting Results & Voting Rights Announcements
BIOSYNEX SA: DECLARATION DU NOMBRE DACTIONS ET DES DROITS DE VOTE AU 28 FEVRIER…
French 23.2 KB
2025-03-04 17:00
Declaration of Voting Results & Voting Rights Announcements
BIOSYNEX SA: DECLARATION DU NOMBRE D’ACTIONS ET DES DROITS DE VOTE AU 28 FEVRIE…
French 127.2 KB
2025-02-13 08:00
Share Issue/Capital Change
BIOSYNEX SA: BIOSYNEX ANNONCE LE SUCCES DE SON AUGMENTATION DE CAPITAL AVEC MAI…
French 120.7 KB
2025-02-12 08:00
Share Issue/Capital Change
BIOSYNEX SA: BIOSYNEX ANNONCE LE SUCCES DE SON AUGMENTATION DE CAPITAL AVEC MAI…
French 120.7 KB
2025-02-12 08:00
Share Issue/Capital Change
BIOSYNEX SA: BIOSYNEX ANNONCE LE SUCCES DE SON AUGMENTATION DE CAPITAL AVEC MAI…
French 120.7 KB
2025-01-22 07:00
Share Issue/Capital Change
BIOSYNEX SA: LANCEMENT D’UNE AUGMENTATION DE CAPITAL AVEC MAINTIEN DU DROIT PRE…
French 543.0 KB

Automate Your Workflow. Get a real-time feed of all Biosynex filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Biosynex via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Genetic Analysis AS Logo
Develops microbiome diagnostics to detect gut dysbiosis for clinical and pharma partners.
Norway GEAN
GEN İLAÇ VE SAĞLIK ÜRÜNLERİ SANAYİ VE TİCARET A.Ş. Logo
Develops and manufactures pharmaceuticals for rare diseases and unmet health needs globally.
Türkiye GENIL
Genomtec S.A. Logo
Develops a mobile platform for rapid, precise genetic diagnostics at the point-of-care.
Poland GMT
Gentian Diagnostics ASA Logo
Develops & manufactures IVD immunoassays for human & veterinary disease diagnostics.
Norway GENT
GlaxoSmithKline PLC Logo
Develops vaccines and specialty medicines for infectious diseases, HIV, oncology, and immunology.
United Kingdom GSK
GNI  Group Ltd. Logo Japan 2160
Gour Medical Logo
Developed veterinary diagnostics and treatments for companion and production animals.
France MLGML
Grifols S.A. Logo
Develops plasma-derived medicines & biopharma solutions for rare and chronic conditions.
Spain GRF
Grindeks Logo
Pharmaceutical company developing and selling original/generic drugs & APIs globally.
Latvia GRD1R
Haemato AG Logo
Manufacturer & wholesaler of specialty pharma for chronic diseases & aesthetics.
Germany HAEK